One example of a single gene disorder that could potentially be involved in Figure 17 is cystic fibrosis, which is caused by mutations in the CFTR gene. CRISPR technology has the potential to correct these mutations in patient-derived iPSCs, providing a possible avenue for gene therapy in treating cystic fibrosis.
So, while the specific single gene disorder involved in Figure 17 is not mentioned in the provided information, it is possible that CRISPR technology could be used to improve single gene disorders such as cystic fibrosis.